Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the-629C > A CETP promoter polymorphism in GH-receiving hypopituitary patients

Robin P. F. Dullaart*, Jeroen L. Schols, Gerrit van der Steege, Peter M. J. Zelissen, Wim J. Sluiter, Andre P. van Beek

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the-629C > A CETP promoter polymorphism in GH-receiving hypopituitary patients'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology

Keyphrases